Compare CDNS & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNS | MDT |
|---|---|---|
| Founded | 1988 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.8B | 107.0B |
| IPO Year | 1994 | 2014 |
| Metric | CDNS | MDT |
|---|---|---|
| Price | $330.41 | $83.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 21 |
| Target Price | ★ $375.00 | $108.21 |
| AVG Volume (30 Days) | 2.0M | ★ 7.3M |
| Earning Date | 04-27-2026 | 06-03-2026 |
| Dividend Yield | N/A | ★ 3.58% |
| EPS Growth | ★ 5.45 | 3.32 |
| EPS | 1.23 | ★ 3.73 |
| Revenue | $5,296,759,000.00 | ★ $36,364,000,000.00 |
| Revenue This Year | $16.00 | $8.91 |
| Revenue Next Year | $12.39 | $6.54 |
| P/E Ratio | $268.67 | ★ $21.99 |
| Revenue Growth | ★ 14.12 | 8.43 |
| 52 Week Low | $262.75 | $73.31 |
| 52 Week High | $416.69 | $106.33 |
| Indicator | CDNS | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 34.15 | 55.87 |
| Support Level | $331.56 | $78.24 |
| Resistance Level | $341.31 | $84.54 |
| Average True Range (ATR) | 13.52 | 1.91 |
| MACD | -4.80 | -0.05 |
| Stochastic Oscillator | 16.96 | 61.47 |
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enables system-level analysis and verification solutions.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.